PFBT
LAB icon

Parkside Financial Bank & Trust’s Standard BioTools LAB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184 Sell
200
-413
-67% -$500 ﹤0.01% 2645
2025
Q4 		$785 Buy
613
+413
+207% +$555 ﹤0.01% 2417
2025
Q3 		$260 Hold
200
– – ﹤0.01% 2643
2025
Q2 		$240 Hold
200
– – ﹤0.01% 2659
2025
Q1 		$216 Buy
+200
New +$281 ﹤0.01% 2668

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Parkside Financial Bank & Trust's LAB Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Standard BioTools (LAB) stake by 67% in Q1 2026, selling an estimated $500 and leaving 200 shares worth $184. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

Parkside Financial Bank & Trust first reported a position in LAB in Q1 2025 and has held it in 5 quarters since. The position peaked at $785 in Q4 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Parkside Financial Bank & Trust held 200 shares of Standard BioTools worth $184 as of Q1 2026.
  • Parkside Financial Bank & Trust sold 413 Standard BioTools shares in Q1 2026, an estimated $500.
  • Standard BioTools made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2645 holding.
  • Parkside Financial Bank & Trust first reported a position in Standard BioTools in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Standard BioTools position peaked at $785 in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.